Stomach Cancer
📧 Sign up to get email alerts when something new happens for Stomach Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Early Detection of Esophageal Cancer
An NCI-sponsored clinical trial evaluating early detection of esophageal cancer has been terminated. The study also related to stomach neopl…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Docetaxel and Irinotecan in Gastric Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and irinotecan in gastric/stomach cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy [Phase 2, Phase 3]
A trial update on KN026 in combination with chemotherapy for HER2-positive stomach (gastric) cancer patients after failure of first-line the…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation [Phase 2]
Phase II trial update for neoadjuvant laparoscopic HIPEC with chemoradiation in gastric/stomach cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer [Phase 1]
Phase 1 trial update of PIPAC nab-paclitaxel for peritoneal carcinomatosis in stomach, pancreas, breast, and ovarian cancers with completed …
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Perioperative FLOT vs Adjuvant XELOX for CA Stomach [Phase 3]
Phase 3 trial updating perioperative FLOT vs adjuvant XELOX for stomach cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer [Phase 2]
Phase 2 trial evaluating fruquintinib with sintilimab as first-line therapy for stomach cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma [Phase 2]
Phase 2 trial evaluating perioperative mFOLFOX plus pembrolizumab for gastroesophageal junction and stomach adenocarcinoma is currently acti…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC [Phase 2]
Phase 2 trial investigating perioperative chemotherapy combined with tislelizumab and trastuzumab for stomach cancer/early gastric cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with combination chemotherapy before surgery for locally advanced esophageal or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) [Phase 2, Phase 3]
Phase 2/3 trial updating perioperative therapy for gastric or gastroesophageal junction cancer comparing FLOT versus FLOT with ramucirumab. …
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
Clinical trial investigating predictors of tumor response and radiation therapy side effects in gastrointestinal cancers; terminated with po…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating alpelisib with paclitaxel in PIK3CA-altered gastric cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC [Phase 2]
Phase 2 trial comparing POF, FOLFOX, and FOLFOX plus paclitaxel in advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) [Phase 1]
Phase 1 trial of TAK-164 in advanced GI cancers expressing GCC was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer [Phase 3]
A Phase 3 trial comparing HX008 plus irinotecan to placebo plus irinotecan as second-line treatment for advanced gastric cancer is ongoing (…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating FOLFOX alone or with AMG 102 or panitumumab as first-line treatment for advanced gastroesophageal adenocarcinoma; s…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer [Phase 2, Phase 3]
A Phase 2/3 trial comparing FLOT with and without HER2-targeted therapy (Herceptin/Pertuzumab) as perioperative treatment for HER-2 expressi…
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) [Phase 1, Phase 2]
A clinical trial update for neoadjuvant chemotherapy with PISOXO in locally invaded gastric cancer spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update on hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer [Phase 3]
Phase 3 trial updating adjuvant chemotherapy with Nab-paclitaxel plus S-1 for stage III gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients [Phase 4]
A Phase 4 trial evaluating pre-emptive geno- and phenotyping in patients treated with 5-fluorouracil or capecitabine for various GI cancers.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) [Phase 2]
Phase 2 trial evaluating preoperative chemotherapy and chemoradiotherapy for adenocarcinoma of the stomach and gastroesophageal junction has…